FDA Inspection 1217492 — Terrebonne General Health System

Terrebonne General Health System — FEI 2370425

The FDA completed an inspection of Terrebonne General Health System on August 24, 2023 in Houma, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 24, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Houma, LA (United States)